GlassScriptPhysician profile
John Douglas Graham, III
NPI 1669443198
$1,444.58
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,020 · 2020: $88.34 · 2021: $320 · 2023: $16.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $370.87 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $203.44 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $177.11 | 2019-2020 | |
| Merz North America, INC. | $160.23 | 2021 | |
| Pfizer INC. | $136.48 | 2019-2021 | |
| Boston Scientific Corporation | $97.23 | 2019-2023 | |
| Amgen INC. | $74.29 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $47.68 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $42.16 | 2019 | |
| Amarin Pharma, INC. | $40.20 | 2019-2021 | |
| Novo Nordisk INC | $29.23 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $16.35 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.57 | 2019 | |
| Glaxosmithkline, LLC. | $13.26 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.15 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.33 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.